Baxter Healthcare Corporation

• NCT04094038

  Collaborator, Phase 4, Active, not recruiting, 166 people, 18 Sept 2019

• NCT03477344

  Collaborator, Phase 3, Completed, 348 people, 26 Mar 2018

• NCT02631525

  Collaborator, Phase 4, Completed, 40 people, 16 Dec 2015

• NCT01985854

  Collaborator, Phase 4, Status unknown, 60 people, 15 Nov 2013

• NCT01270620

  Collaborator, Phase 4, Completed, 100 people, 5 Jan 2011

• NCT00745225

  Collaborator, Phase 4, Completed, 160 people, 3 Sept 2008

• NCT00508495

  Phase 3, Completed, 148 people, 30 Jul 2007

• NCT00406679

  Phase 3, Completed, 135 people, 4 Dec 2006

• NCT00358553

  Phase 1, Completed, 1 Aug 2006

• NCT00231582

  Collaborator, Phase 2, Completed, 50 people, 4 Oct 2005

• NCT00007813

  Collaborator, Phase 1, Completed, 21 people, 2 Apr 2004

• Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease

  Fees or honoraria, 31 Aug 2026

• Primary results of the VICTORION-NOVEL (LDL-C management Program in atherosclerotic cardiovascular disease patients with elevated LDL-C) lipid optimization multicenter implementation trial

  Consulting or advice, Grants or research support, Board or leadership role, 16 Jul 2026

• Protein Intake and Mortality in Older Adults With Chronic Kidney Disease

  Grants or research support, 1 Aug 2024

• MKL1 cooperates with p38MAPK to promote vascular senescence, inflammation, and abdominal aortic aneurysm

  Consulting or advice, 20 Feb 2021

Sources: pubmed.ncbi.nlm.nih.gov